科技美丽生活
让成千上万的家庭和人类生活受益于实验室的科学技术成果
康集团成立于2012年，以生物科技、美容连锁为核心业务集群，构建全产业链式的国际化企业运营体系，塑造生物科技应用于社会生活的核心价值。斥资5.2亿建设的慧康生物科技产业园，总建筑面积6.5万平方米，是按照国际标准厂房、高科技产品、现代化管理、跨越式发展的理念进行规划、设计和建设的国际化规模产业园区。
慧康集团旗下的生物科技事业始于2001年，成立的陕西慧康生物科技有限责任公司专注于活性蛋白与多肽领域研究23年，发起的“中国肽库”项目，将建立蛋白与多肽原料研发与供应基地，抢占“蓝海战略”引领下的价值创新高地。
HuiKang Culture
生物科技进化人类生活。
共创、共享、共赢
为员工谋福利，为企业创价值，为社会做贡献。
知行合一，敬天爱人。
以人为本、以德为先、机会均等、任贤使能。
创始人、执行董事、董事长
副董事长、执行董事
2023
The product ecosystem encompasses innovative drugs, biomedicine, medical devices, and high-tech biological skincare products, presenting a comprehensive range.
2022
The sales revenue of new raw material-based skincare products in the daily chemical industry has achieved a new breakthrough.
2021
Huikang Bio-Tech was the only Chinese enterprise in the new material group of the Global Top 100 Innovative list.
2021
Huikang Bio-Tech was subsidize by the State Key Laboratory of Mechanical Behavior of Materials, Ministry of Education.
2021
HuiKang Novel Coronavirus blocking peptide project obtained class I fund of Postdoctoral Innovation Base.
2020
Argireline Serum received the honor of Shaanxi Key New Products.
2020
The scientific achievements of collagen have been published in famous academic journal International Journal of Biological Macromolecules.
2020
The brand ACTII was born.
2019
HuiKang Biotechnology Industrial Park officially put into operation.
2018
Successfully hosted the International Protein and Peptides Conference, a sub forum of the 2018 Global Hard and Core Conference and the Belt and Road Innovation conference.
2018
Introduction article of HuiKang • China Peptide Bank published in the sub Journal of Nature.
2017
Launched the Phase I Construction Plan of HuiKang• China Peptide Bank.
2017
Started Bio-tech cosmetics business.
2017
The bio-tech cosmetics brand Ye New Skin was debuted.
2016
Initiate the R&D of two national class I new drugs.
2012
Xi 'an HuiKang Enterprise Operation Management Group Co., LTD was founded.
2012
Obtained the first national invention patent.
2011
HuiKang Biotechnology Industrial Park broke groud and started building.
2011
A series of skin care products with protein and peptides as the core ingredients have came out after one and another..
2011
Recombinant human collagen was successfully developed..
2010
HuiKang R&D Center was set up.
2001
Shaanxi Dongda Biochemical Technology Co., LTD. (the predecessor of HuiKang Bio-Tech) was established.
截至2024年10月，慧康集团旗下子公司共有166项专利，包括国家发明专利88项、外观专利18项、实用新型专利29项，中国香港专利17项、国际专利14项。
投资5.2亿元，占地40亩，建筑面积6.5万平方米。
合成多肽中试放大系统
蛋白多肽制剂中试放大生产系统
重组蛋白中试放大生产系统
“中国肽库”项目计划构建一个序列精准的商业肽库，或称平行肽库，共计超过175000条肽，未来将成为人类共享的宝库。
Copyright © 2017 慧康集团保留所有权利／
陕ICP备17008662号-1友情链接：
慧康生物研发中心Powered by
Coolsite360
